Vimarsana
Biggest News Aggregation in the World

Page 11 - Contract Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Contract Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Contract Development Today - Breaking & Trending Today

US lawmakers ask FBI for briefing on GenScript Biotech's links to China - Vimarsana News

US lawmakers ask FBI for briefing on GenScript Biotech's links to China

The U.S. House of Representatives committee on China has asked the FBI and the intelligence community for a briefing on GenScript Biotechnology Co and three subsidiaries to determine if the Chinese...

US lawmakers ask FBI for briefing on GenScript Biotech's links to China | WKZO | Everything Kalamazoo - Vimarsana News

US lawmakers ask FBI for briefing on GenScript Biotech's links to China | WKZO | Everything Kalamazoo

By Karen Freifeld (Reuters) - The U.S. House of Representatives committee on China has asked the FBI and the intelligence community for a briefing on GenScript Biotechnology Co and three subsidiaries to determine if the Chinese Communist Party has ...

Source: wkzo.com
US lawmakers ask FBI for briefing on GenScript Biotech's links to China By Reuters - Vimarsana News

US lawmakers ask FBI for briefing on GenScript Biotech's links to China By Reuters

US lawmakers ask FBI for briefing on GenScript Biotech's links to China

Jubilant Pharmova Q4 net profit jumps over two-fold to Rs 61 crore - Vimarsana News

Jubilant Pharmova Q4 net profit jumps over two-fold to Rs 61 crore

Jubilant Pharmova Chairman Shyam S Bhartia said that in the generics business, the company is growing profitably in the non US international markets.

Jubilant Pharmova's Profits Surge Over Two-Fold in Q4 2024 - Vimarsana News

Jubilant Pharmova's Profits Surge Over Two-Fold in Q4 2024

Jubilant Pharmova reported a more than two-fold increase in consolidated profit after tax, reaching Rs 61 crore for Q4 2024. The company's total income from operations stood at Rs 1,773 crore. For the full fiscal year, net profit surged to Rs 195 crore, with significant growth plans announced for international and US markets.